Technology and product review Biatain® Silicone dressings: A case series evaluation


Figure 3. Distribution of wound types at study inclusion. 5%


31% 23% 41%


Pressure ulcer Donor sites DFU Leg ulcer


were the preferred choices (in nine and ten participants, respectively) [Figure 4]. Alginate/Hydrofiber® dressings were the most commonly used in participants with leg ulcers, while foam dressings were most common among those with diabetic foot ulcers. Among participants with pressure ulcers, treatments were equally split between alginate/Hydrofiber and foam dressings. Among participants with donor site wounds, no dressing was applied at study inclusion.


Wound assessments At study entry, 81% of leg ulcers and 100% of pressure ulcers had been present for >6 months and 78% of diabetic foot ulcers had been present for 4−6 months. The number of dressing changes for the


dressings used at study inclusion were two per week for pressure ulcers (n=2), two to three per week for leg ulcers (n=16) and an average of three per week for diabetic foot ulcers (n=9). Exudate levels were assessed according to


level (low, moderate or high), with high and moderate levels of exudate requiring more frequent dressing changes. Overall, 67% had moderately exuding wounds (69%, 78% and 67% among leg ulcers, diabetic foot ulcers and donor site wounds, respectively). Twenty percent of all participants had low-exuding wounds (50% among pressure ulcers) and 13% had high-exuding wounds (50% among pressure ulcers) [Figure 5]. The state of the surrounding skin was assessed in all participants (n=39) and was normal in 14, fragile in 14, irritated in nine, macerated in eight and painful in two participants (note that multiple choices for each case were allowed). Upon entry into the product evaluation, 74% of cases received the standard Biatain Silicone product. The distribution according to wound type was Biatain Silicone among 75% of leg ulcers, 50% of pressure ulcers, 44% of diabetic foot ulcers and 100% of donor site wounds, while the remaining received Biatain


Figure 4. Dressings used at study inclusion. *Multiple choices were allowed. †”Other treatments” were antimicrobial dressing, honey dressing, gauze and film.


20 18 16 14 12 10 8 4 2 0


Alginate / Hydrofiber Foam w/silicone adhesive Foam Hydrocolloid Gel Other treatments


Leg ulcers


Pressure ulcers


DFU


Silicone Lite. During the study, participants received Biatain Silicone dressings (Standard or Lite) for two weeks or six dressing changes. Overall, the mean wear time was 4.1 (range 1−11) days with a majority of dressing changes being routine dressing changes.


HCP experience with the Biatain Silicone dressings When asked, “To what extent was the dressing easy to apply?” the HCPs rated the application as very easy or easy to apply in 92% of the cases, while in 8% of cases it was rated as average. No one rated the application as difficult or very difficult [Figure 6]. Evaluation of the dressings’ ability to absorb


exudate showed that in 90% of the cases, the HCPs found them to be very good or good [Figure 7]. When comparing with previously


13% 20% 67%


High exuding Moderate exuding Low exuding


REFERENCES


Figure 5. Distribution of wound exudate levels at study inclusion.


60


10 20 30 40 50


0 Very easy Easy Average Difficult Figure 6. Ease of product application. Wounds International Vol 5 | Issue 1 | ©Wounds International 2014 | www.woundsinternational.com 21 Very difficult


1. European Wound Management Association (2008) Position Document: Hard-to-Heal Wounds: A Holistic Approach. MEP Ltd, London


2. Wounds UK (2013) Best Practice Statement. Effective exudate management. Available at: http:// www.wounds-uk.com/best-practice- statements (accessed 20.02.2014)


3. Colwell JC et al (2011) MASD part 3: peristomal moisture- associated dermatitis and periwound moisture- associated dermatitis: a consensus. J Wound Ostomy Continence Nurs 38(5): 541–53


PP total


Per cent (%)


N* (multiple choices)


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30